- Ruboxistaurin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review of Randomized Clinical Trials
-
Dipika Bansal, Yogesh Badhan, Kapil Gudala, Fabrizio Schifano
-
Diabetes Metab J. 2013;37(5):375-384. Published online October 17, 2013
-
DOI: https://doi.org/10.4093/dmj.2013.37.5.375
-
-
7,168
View
-
72
Download
-
51
Crossref
-
Abstract
PDFPubReader
- Background
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. Protein kinase C (PKC) inhibitor's has been thought to be a potential disease modifying drug's in DPN as it slows or reverse neuropathy's progression. To assesses the efficacy and safety of ruboxistaurin on the progression of symptoms, signs, or functional disability in DPN. MethodsA systematic review of the literature databases like PubMed, ProQuest, EBSCO, EMBASE, and Cochrane Central was performed up to August 2012. We included randomized controlled trials (RCTs) comparing PKC inhibitor ruboxistaurin (RBX) with control and lasting at least 6 months. Our primary outcome measure was change in neurological examination, measured by neurological total symptom score (NTSS) and vibration detection threshold (VDT). Secondary outcome measures were total quality of life (QoL), skin microvascular blood flow and others. ResultsSix RCTs were included in review. Change in neurological function assessed by NTSS was reported in six studies, out of which significant difference between the RBX and placebo group seen in four studies favouring treatment group while remaining two studies reported no significant difference. VDT was assessed in only one study in which no significant difference seen between RBX and placebo group. Two studies reported significant improvement in QoL data. Safety data was reported in only two studies in which none of side effect was related to RBX. ConclusionRBX had effects on DPN in some studies, but the evidence is not enough for meta-analysis and firm conclusion.
-
Citations
Citations to this article as recorded by
- Painful Diabetic Neuropathy: The Need for New Approaches
Andrea M. Yeung, Jingtong Huang, Kevin T. Nguyen, Nicole Y. Xu, Lorenzo T. Hughes, Brajesh K. Agrawal, Niels Ejskjaer, David C. Klonoff Journal of Diabetes Science and Technology.2024; 18(1): 159. CrossRef - Cell metabolism pathways involved in the pathophysiological changes of diabetic peripheral neuropathy
Yaowei Lv, Xiangyun Yao, Xiao Li, Yuanming Ouyang, Cunyi Fan, Yun Qian Neural Regeneration Research.2024; 19(3): 598. CrossRef - Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila
Daewon Lee, Eunju Yoon, Su Jin Ham, Kunwoo Lee, Hansaem Jang, Daihn Woo, Da Hyun Lee, Sehyeon Kim, Sekyu Choi, Jongkyeong Chung Nature Communications.2024;[Epub] CrossRef - Non-Muscle Myosin IIC as a Prognostic and Therapeutic Target in Cancer
Ghulam Jilany Khan, Sajal Salman, Zhu Chen, Song Li, Hui Chen, Yan Deng, Nongyue He Journal of Biomedical Nanotechnology.2024; 20(3): 438. CrossRef - New Horizons in Diabetic Neuropathies: An Updated Review on their Pathology, Diagnosis, Mechanism, Screening Techniques, Pharmacological, and Future Approaches
Namra Aziz, Biswajit Dash, Pranay Wal, Prachi Kumari, Poonam Joshi, Ankita wal Current Diabetes Reviews.2024;[Epub] CrossRef - Nanoformulations of flavonoids for diabetes and microvascular diabetic complications
Kopal Agarawal, Yogesh Anant Kulkarni, Sarika Wairkar Drug Delivery and Translational Research.2023; 13(1): 18. CrossRef - Determination of Ruboxistaurin analysis in rat plasma utilizing LC–MS/MS technique
Bushra T. AlQuadeib, Fadilah S. Aleanizy, Fulwah Y. Alqahtani, Rehab A. Alshammari, Amal Aldarwesh, Ibrahim Alsarra Saudi Pharmaceutical Journal.2023; 31(4): 547. CrossRef - New perspectives in diabetic neuropathy
Stephanie A. Eid, Amy E. Rumora, Bogdan Beirowski, David L. Bennett, Junguk Hur, Masha G. Savelieff, Eva L. Feldman Neuron.2023; 111(17): 2623. CrossRef - Issues and challenges in diabetic neuropathy management: A narrative review
Che Aishah Nazariah Ismail World Journal of Diabetes.2023; 14(6): 741. CrossRef - Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status
Kai Guo, Masha G Savelieff, Amy E Rumora, Fadhl M Alakwaa, Brian C Callaghan, Junguk Hur, Eva L Feldman The Journal of Clinical Endocrinology & Metabolism.2022; 107(4): 1091. CrossRef - The crosstalk among TLR2, TLR4 and pathogenic pathways; a treasure trove for treatment of diabetic neuropathy
Seyed Hossein Aghamiri, Khalil Komlakh, Mehran Ghaffari Inflammopharmacology.2022; 30(1): 51. CrossRef - 10.6-μm infrared laser as adjuvant therapy for diabetic peripheral neuropathy: study protocol for a double-blind, randomized controlled trial
Lin Lin, Yi Chen, Yuxia Li, Ke Cheng, Haiping Deng, Jianping Lu, Ling Zhao, Xueyong Shen Trials.2022;[Epub] CrossRef - Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy?
Dalal Y. Al-Bazz, Andrew J. Nelson, Jamie Burgess, Ioannis N. Petropoulos, Jael Nizza, Anne Marshall, Emily Brown, Daniel J. Cuthbertson, Andrew G. Marshall, Rayaz A. Malik, Uazman Alam Diagnostics.2022; 12(3): 731. CrossRef - Prospective dietary radical scavengers: Boon in Pharmacokinetics, overcome insulin obstruction via signaling cascade for absorption during impediments in metabolic disorder like Diabetic Mellitus
Varuna Suresh, John Kunnath, Amala Reddy Journal of Diabetes & Metabolic Disorders.2022; 21(1): 1149. CrossRef - The Treatment of Painful Diabetic Neuropathy
Gordon Sloan, Uazman Alam, Dinesh Selvarajah, Solomon Tesfaye Current Diabetes Reviews.2022;[Epub] CrossRef - Effect of Cognitive-Behavioral Therapy or Mindfulness Therapy on Pain and Quality of Life in Patients with Diabetic Neuropathy: A Systematic Review and Meta-Analysis
Yuan Bai, Jun-Hong Ma, Ying Yu, Zhi-Wen Wang Pain Management Nursing.2022; 23(6): 861. CrossRef - Emerging drugs for the treatment of diabetic nephropathy
Yoon Kook Kim, Xinyuan Ning, Kashif M. Munir, Stephen N. Davis Expert Opinion on Emerging Drugs.2022; 27(4): 417. CrossRef - Novel treatment modalities for painful diabetic neuropathy
A. Rastogi, E.B. Jude Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(1): 287. CrossRef - Effectiveness and safety of low-level laser therapy in diabetic peripheral neuropathy: a protocol for a systematic review and meta-analysis
Lin Lin, Jingjing Li, Jingshan Lin, Shiheng Tang, Yuxia Li Systematic Reviews.2021;[Epub] CrossRef - Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes
Amy E. Rumora, Kai Guo, Fadhl M. Alakwaa, Signe T. Andersen, Evan L. Reynolds, Marit E. Jørgensen, Daniel R. Witte, Hatice Tankisi, Morten Charles, Masha G. Savelieff, Brian C. Callaghan, Troels S. Jensen, Eva L. Feldman Annals of Clinical and Translational Neurology.2021; 8(6): 1292. CrossRef - Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Gordon Sloan, Dinesh Selvarajah, Solomon Tesfaye Nature Reviews Endocrinology.2021; 17(7): 400. CrossRef - Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies
Komal Arora, Pushpa C. Tomar, Vandana Mohan Journal of Diabetes & Metabolic Disorders.2021; 20(2): 1773. CrossRef - Synthesis and Antiplasmodial Activity of Bisindolylcyclobutenediones
Duc Hoàng Lande, Abed Nasereddin, Arne Alder, Tim W. Gilberger, Ron Dzikowski, Johann Grünefeld, Conrad Kunick Molecules.2021; 26(16): 4739. CrossRef - High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy
Chialin Cheng, Surya A. Reis, Emily T. Adams, Daniel M. Fass, Steven P. Angus, Timothy J. Stuhlmiller, Jared Richardson, Hailey Olafson, Eric T. Wang, Debasis Patnaik, Roberta L. Beauchamp, Danielle A. Feldman, M. Catarina Silva, Mriganka Sur, Gary L. Joh Scientific Reports.2021;[Epub] CrossRef - Management of diabetic neuropathy
Simona Cernea, Itamar Raz Metabolism.2021; 123: 154867. CrossRef - 29th Annual GP2A Medicinal Chemistry Conference
Jean-Jacques Helesbeux, Laura Carro, Florence O. McCarthy, Vânia M. Moreira, Francesca Giuntini, Niamh O’Boyle, Susan E. Matthews, Gülşah Bayraktar, Samuel Bertrand, Christophe Rochais, Pascal Marchand Pharmaceuticals.2021; 14(12): 1278. CrossRef - Understanding Diabetic Neuropathy: Focus on Oxidative Stress
Lei Pang, Xin Lian, Huanqiu Liu, Yuan Zhang, Qian Li, Yin Cai, Haichun Ma, Xin Yu Oxidative Medicine and Cellular Longevity.2020; 2020: 1. CrossRef - Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors
Triantafyllos Didangelos, Aristidis Veves Current Vascular Pharmacology.2020; 18(2): 158. CrossRef - Mechanisms of small nerve fiber pathology
Franziska Gross, Nurcan Üçeyler Neuroscience Letters.2020; 737: 135316. CrossRef - Whole-Genome Sequencing of Finnish Type 1 Diabetic Siblings Discordant for Kidney Disease Reveals DNA Variants associated with Diabetic Nephropathy
Jing Guo, Owen J. L. Rackham, Niina Sandholm, Bing He, Anne-May Österholm, Erkka Valo, Valma Harjutsalo, Carol Forsblom, Iiro Toppila, Maija Parkkonen, Qibin Li, Wenjuan Zhu, Nathan Harmston, Sonia Chothani, Miina K. Öhman, Eudora Eng, Yang Sun, Enrico Pe Journal of the American Society of Nephrology.2020; 31(2): 309. CrossRef - SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice
Xialin Zhu, Yun Chen, Xu Xu, Xiaoju Xu, Yin Lu, Xi Huang, Jinpei Zhou, Lihong Hu, Jiaying Wang, Xu Shen EBioMedicine.2020; 61: 103061. CrossRef - Targeting Mitochondrial Fission-Fusion Imbalance in Heart Failure
Thiago N. Menezes, Lisley S. Ramalho, Luiz R. G. Bechara, Julio Cesar Batista Ferreira Current Tissue Microenvironment Reports.2020; 1(4): 239. CrossRef - Recent advances in the pathogenesis of microvascular complications in diabetes
Sungmi Park, Hyeon-Ji Kang, Jae-Han Jeon, Min-Ji Kim, In-Kyu Lee Archives of Pharmacal Research.2019; 42(3): 252. CrossRef - Novel Target Sites for Drug Screening: A Special Reference to Cancer, Rheumatoid Arthritis and Parkinson’s Disease
Neeraj Kumar, Anita Singh, Dinesh Kumar Sharma, Kamal Kishore Current Signal Transduction Therapy.2019; 14(2): 107. CrossRef - Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
Saikat Dewanjee, Sonjit Das, Anup Kumar Das, Niloy Bhattacharjee, Anjum Dihingia, Tarun K. Dua, Jatin Kalita, Prasenjit Manna European Journal of Pharmacology.2018; 833: 472. CrossRef - Interventions for Neuropathic Pain: An Overview of Systematic Reviews
Svjetlana Dosenovic, Antonia Jelicic Kadic, Maja Miljanovic, Marina Biocic, Krste Boric, Marija Cavar, Nikolina Markovina, Katarina Vucic, Livia Puljak Anesthesia & Analgesia.2017; 125(2): 643. CrossRef - New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Eva L. Feldman, Klaus-Armin Nave, Troels S. Jensen, David L.H. Bennett Neuron.2017; 93(6): 1296. CrossRef - Rutin suppresses high glucose-induced ACTA2 and p38 protein expression in diabetic nephropathy
Chun-Shan Han, Kai Liu, Ning Zhang, Shi-Wen Li, Hai-Cheng Gao Experimental and Therapeutic Medicine.2017; 14(1): 181. CrossRef - Protein kinase C participation in the mechanisms of vascular tone disturbance upon diabetes mellitus. Part 4
I. Kizub, O. Kharchenko, O. Kostiuk, L. Ostapchenko, K. Klymenko, A. Soloviev Bulletin of Taras Shevchenko National University of Kyiv. Series: Problems of Physiological Functions Regulation.2016; 21(2): 61. CrossRef - Emerging drugs for diabetic peripheral neuropathy and neuropathic pain
Nikolaos Papanas, Dan Ziegler Expert Opinion on Emerging Drugs.2016; 21(4): 393. CrossRef - Pancreatic β Cell Mass Death
Husnia I. Marrif, Salma I. Al-Sunousi Frontiers in Pharmacology.2016;[Epub] CrossRef - Efficacy and safety of prostaglandin E1 plus lipoic acid combination therapy versus monotherapy for patients with diabetic peripheral neuropathy
De-Qi Jiang, Ming-Xing Li, Yan-Jiao Ma, Yan Wang, Yong Wang Journal of Clinical Neuroscience.2016; 27: 8. CrossRef - Nonbiological pharmacotherapies for the treatment of diabetic macular edema
Aniruddha Agarwal, Jacob Parriott, Sibel Demirel, Colby Argo, Yasir Jamal Sepah, Diana V Do, Quan Dong Nguyen Expert Opinion on Pharmacotherapy.2015; 16(17): 2625. CrossRef - Present and Future in the Treatment of Diabetic Kidney Disease
Borja Quiroga, David Arroyo, Gabriel de Arriba Journal of Diabetes Research.2015; 2015: 1. CrossRef - Choosing drugs for the treatment of diabetic neuropathy
Majed Alabdali, Mohammad Qrimli, Carolina Barnett, Alon Abraham, Ari Breiner, Hans D Katzberg, Danah Aljaafari, Hana Albulaihe, Bruce A Perkins, Vera Bril Expert Opinion on Pharmacotherapy.2015; 16(12): 1805. CrossRef - Burning through the pain: treatments for diabetic neuropathy
S. Javed, U. Alam, R. A. Malik Diabetes, Obesity and Metabolism.2015; 17(12): 1115. CrossRef - Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220
Abdullah Mayati, Arnaud Bruyere, Amélie Moreau, Elodie Jouan, Claire Denizot, Yannick Parmentier, Olivier Fardel, Jeff M Sands PLOS ONE.2015; 10(12): e0144667. CrossRef - Targeting caveolin-3 for the treatment of diabetic cardiomyopathy
Lucy Murfitt, Gareth Whiteley, Mohammad M. Iqbal, Ashraf Kitmitto Pharmacology & Therapeutics.2015; 151: 50. CrossRef - Protein kinase C in enhanced vascular tone in diabetes mellitus
Igor V. Kizub, Kateryna I. Klymenko, Anatoly I. Soloviev International Journal of Cardiology.2014; 174(2): 230. CrossRef - Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy
Houliang Deng, JinJin Yin, JingJing Zhang, Qian Xu, Xiaoxia Liu, Li Liu, Zhuomin Wu, Aimin Ji Endocrine.2014; 46(3): 445. CrossRef - Efficacy of α-lipoic acid in diabetic neuropathy
Nikolaos Papanas, Dan Ziegler Expert Opinion on Pharmacotherapy.2014; 15(18): 2721. CrossRef
|